Utah Medical Products, Inc. (UTMD) NASDAQ

66.82

+0.64(+0.97%)

Updated at June 02 04:00PM

Currency In USD

Valuation

Market Cap185.23M
Enterprise Value99.7M
P/E Ratio19.62
PEG Ratio-1.63
Price/Sales Ratio5.67
Price/Book Ratio1.77
Enterprise/Revenue3.35
Enterprise/EBITDA8.34

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.29
Operating Margin0.29

Management Effectiveness

Return On Assets0.09
Return On Equity0.09

Income Statement

Revenue38.52M
Revenue/Share11.78
Gross Profit19.88M
EBITDA17.06M
Net Income11.29M
Diluted EPS3.48

Balance Sheet

Total Cash87.41M
Total Cash/Share27.44
Total Debt210,000
Total Debt/Equity0
Current Ratio28.64
Book Value Per Share37.79

Price History

52-Week Change22.09
52-Week High71.81
52-Week Low52
Moving Average 50 Days65.42
Moving Average 200 Days61.74

Statistics

Average Volume12,647
Shares Outstanding3.18M
% Held by Institutions68.47

Dividend And Splits

Trailing Annual Dividend Rate1.23
Trailing Annual Dividend Yield1.84
Payout Ratio0.36
Last Split Factor3:2
Last Split DateMarch 22, 1993